Zeiss seeks FDA approval of SMILE procedure for astigmatic myopia

SAN DIEGO — Carl Zeiss Meditec is moving forward with a FDA phase 2 clinical trial for ReLEx small incision lenticule extraction, a company official said here.During a media briefing, Dirk Muehlhoff, the company’s head of cataract and refractive surgery, said that Zeiss is seeking approval of a new indication for the ReLEx SMILE procedure, astigmatic myopia.